Evaluation of an Apple Juice Drink With POs-Ca
This study has been completed.
Sponsor:
Hitomi Mita
Information provided by (Responsible Party):
Hitomi Mita, Tokyo Medical and Dental University
ClinicalTrials.gov Identifier:
NCT01552252
First received: March 7, 2012
Last updated: March 8, 2012
Last verified: March 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The null hypothesis tested was that there are no differences in the taste palatability of the apple juices before and after adding POs-Ca.
| Condition | Intervention | Phase |
|---|---|---|
|
Food Preferences |
Dietary Supplement: apple juice Dietary Supplement: apple juice with 0.5% POs-Ca Dietary Supplement: apple juice with 1% POs-Ca Dietary Supplement: apple juice with 1.5% POs-Ca Dietary Supplement: apple juice with 2% POs-Ca |
Phase 0 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Intervention Model: Crossover Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Supportive Care |
| Official Title: | Development and Evaluation of a Low Erosive Apple Juice Drink With Phosphoryl Oligosaccharides of Calcium (POs-Ca) |
Resource links provided by NLM:
Further study details as provided by Tokyo Medical and Dental University:
Primary Outcome Measures:
- Visual Analogue Scale of taste palatability [ Time Frame: At time when the subjects have finished drinking, an expected average of 10 minutes ] [ Designated as safety issue: No ]
Tasters were first asked to drink the unaltered (0% POs-Ca) juice, to get familiar with the taste.
After that they drank each of the 5 juices in a random order, and evaluated the taste by marking an analogue scale ranging from 0 to 100 which was printed horizontally on a sheet of paper.
| Enrollment: | 30 |
| Study Start Date: | March 2010 |
| Study Completion Date: | March 2012 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
| Placebo Comparator: 0% POs-Ca |
Dietary Supplement: apple juice
unaltered(0% POs-Ca) commercially available apple juice
|
| Active Comparator: 0.5% POs-Ca |
Dietary Supplement: apple juice with 0.5% POs-Ca
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 0.5% by weight to a commercially available apple juice
|
| Active Comparator: 1% POs-Ca |
Dietary Supplement: apple juice with 1% POs-Ca
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 1% by weight to a commercially available apple juice
|
| Active Comparator: 1.5% POs-Ca |
Dietary Supplement: apple juice with 1.5% POs-Ca
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 1.5% by weight to a commercially available apple juice
|
| Active Comparator: 2% POs-Ca |
Dietary Supplement: apple juice with 2% POs-Ca
Phosphoryl Oligosaccharides of Calcium (POs-Ca) in the form of powder was added at concentrations of 2% by weight to a commercially available apple juice
|
Eligibility| Ages Eligible for Study: | 18 Years to 25 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Criteria
Inclusion Criteria:
- healthy adult subjects
- No eating or drinking within 30 minutes before the start time of the trials
- No tooth brushing within 30 minutes before the start time of the trials
Exclusion Criteria:
- apple hypersensibility
Contacts and Locations
More Information
No publications provided
| Responsible Party: | Hitomi Mita, Development and Evaluation of a Low Erosive Apple Juice Drink with Phosphoryl Oligosaccharides of Calcium., Tokyo Medical and Dental University |
| ClinicalTrials.gov Identifier: | NCT01552252 History of Changes |
| Other Study ID Numbers: | POs-Ca02 |
| Study First Received: | March 7, 2012 |
| Last Updated: | March 8, 2012 |
| Health Authority: | Japan: Pharmaceuticals and Medical Devices Agency |
Keywords provided by Tokyo Medical and Dental University:
|
POs-Ca calcium additives drink |
ClinicalTrials.gov processed this record on May 22, 2013